We are a functional service company, supporting biotech and pharma during all stages of preclinical drug discovery, from the screening of chemical libraries to the validation of candidate compounds and repurposed drugs.

With our growing portfolio of comprehensive in vitro disease models, combined with cutting-edge platforms and multiparametric readouts, we provide our clients more relevant and reliable preclinical data.

Acting as a high-quality outsourced laboratory, we engage in a constant scientific interconnection with our partners, understanding their biological needs and tailoring customized solutions.

Drug development is time consuming, costly, and inefficient. By increasing the confidence of cell-based data we efficiently push forward your preclinical programs.